IP Library Granted Patent US 12685865
Granted Patent B2
US 12685865 · App. 18/394,314 · Granted Jul 21, 2026

Systems and methods for treating obstructive sleep apnea with automatic starts and stops

Inventors: Brian Shelton (Ventura, CA); Robert J. Greenberg (Los Angeles, CA)
Assignee: THE ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH
A61N1/36139A61N1/3601A61N1/3611A61N1/3615A61N1/36175
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12685865
App. No.
18/394,314
Granted
Jul 21, 2026
Kind
B2
Abstract

The present disclosure generally relates to systems and methods for detecting and/or treating obstructive sleep apnea (OSA) experienced by a subject, using one or more implanted or external sensors. In some aspects, the systems and methods described herein are configured to classify the human subject as being awake or asleep by comparing a calculated standard deviation and/or variance of one or more respiratory parameters against a predetermined threshold and to control the delivery of stimulation based on this classification.

Claims (62)

1 . A implantable system for treating obstructive sleep apnea (OSA) in a human subject, comprising:

an inertial measurement unit (IMU); and

a controller communicatively linked to the IMU and configured to:

receive sensor data from the IMU, and

determine a position of the human subject from the sensor data; and

a stimulation system, communicatively linked to the controller and configured to deliver stimulation to a nerve which innervates an upper airway muscle of the human subject;

wherein the stimulation system is configured to activate the delivery of stimulation to the nerve when the controller detects a transition in the position of the human subject.

2 . The system of claim 1 , wherein the IMU is an accelerometer.

3 . The system of claim 1 , wherein the controller is further configured to cause the stimulation system to stop or prevent the delivery of stimulation when the human subject is determined to be in an upright, standing, or sitting position.

4 . The system of claim 1 , wherein the controller is further configured to:

maintain a real-time clock;

temporarily pause the delivery of stimulation when the human subject is determined to have switched to an upright, standing, or sitting position during a preset time range; and to resume the delivery of stimulation when the human subject is determined to have returned to a supine, prone or lateral recumbent position.

5 . The system of claim 1 , wherein the controller is further configured to cause the stimulation system to activate the delivery of stimulation based on a preset schedule,

wherein the preset schedule comprises a) a time of day to enter a first mode of operation, b) a time of day to exit the first mode of operation, and c) a first delay timer setting comprising an amount of time to wait before activating the delivery of stimulation, after entering the first mode of operation; and

the first mode of operation comprises a state wherein the controller is further configured to cause the stimulation system to activate the delivery of stimulation when the human subject is determined to have entered a supine, prone or lateral recumbent position, after the first delay time has elapsed.

6 . The system of claim 5 , wherein the controller is further configured to cause the stimulation system to gradually increase a pulse amplitude of the delivered stimulation, upon activation.

7 . The system of claim 5 , wherein the controller is further configured to determine the position of the human subject periodically while in the first mode of operation and to enter a second mode of operation when the human subject is determined to have switched to an upright, standing, or sitting position; and

the second mode of operation comprises a state wherein the controller is configured to cause the stimulation system to pause the delivery of stimulation, and to resume the delivery of stimulation after the human subject is determined to have returned to a supine, prone or lateral recumbent position.

8 . The system of claim 7 , wherein the controller is further configured to cause the stimulation system to resume the delivery of stimulation in the second mode of operation after a preset second delay timer.

9 . The system of claim 1 , wherein the controller is further configured to cause the stimulation system to deliver stimulation to the nerve which innervates an upper airway muscle of the human subject:

a) after determining that the human subject is asleep and detecting transition from a supine position from a prone or lateral position; or

b) after determining that the human subject is asleep and detecting that the human subject has remained in a supine position for a minimum duration.

10 . The system of claim 9 , wherein the controller is further configured to determine that the human subject has rolled on their back based on the sensor data collected by one or more sensors.

11 . The system of claim 9 , wherein the controller is further configured to cause the stimulation system to deliver stimulation to the nerve which innervates an upper airway muscle of the human subject only while the human subject is in a supine position.

12 . The system of claim 1 , wherein the controller is further configured to receive, from a clinician or the human subject, a selection of one or more settings for the delivery of stimulation, wherein the one or more settings comprise a setting allowing or prohibiting the delivery of the stimulation based on a position of the human subject.

13 . The system of claim 12 , wherein the one or more settings comprise a setting allowing or prohibiting the delivery of the stimulation when the human subject is determined to be in a supine, prone, or lateral position.

14 . The system of claim 12 , wherein the one or more settings comprise

a) a duty cycle of the stimulation; or

b) a pulse amplitude of the stimulation.

15 . The system of claim 1 , wherein the controller is further configured to cause the stimulation system to activate the delivery of stimulation to the nerve after a time delay from when the controller detects that the subject is in a recumbent position during a preset time window and pause the delivery of stimulation to the nerve when the subject transitions to an upright position.

16 . A method for treating obstructive sleep apnea (OSA) in a human subject comprising:

collecting sensor data indicative of respiratory activity or a physical state of the human subject using at least an inertial measurement unit (IMU) implanted in the human subject;

receiving the sensor data from the IMU;

determining a position of the human subject from the sensor data;

delivering stimulation to a nerve which innervates an upper airway muscle of the human subject using a stimulation system; and

activating, using the stimulation system, the delivery of stimulation to the nerve upon a detection of a transition in the position of the human subject.

17 . The method of claim 16 , wherein the IMU is an accelerometer.

18 . The method of claim 16 , further comprising: stopping or preventing the delivery of stimulation when the human subject is determined to be in an upright, standing, or sitting position.

19 . The method of claim 16 , further comprising:

maintaining a real-time clock;

temporarily pausing the delivery of stimulation when the human subject is determined to have switched to an upright, standing, or sitting position during a preset time range; and to

resuming the delivery of stimulation when the human subject is determined to have returned to a supine, prone or lateral recumbent position.

20 . The method of claim 16 , further comprising:

activating the delivery of stimulation based on a preset schedule, wherein the preset schedule comprises a) a time of day to enter a first mode of operation, b) a time of day to exit the first mode of operation, and c) a first delay timer setting comprising an amount of time to wait before activating the delivery of stimulation, after entering the first mode of operation; and

the first mode of operation comprises a state to activate the delivery of stimulation when the human subject is determined to have entered a supine, prone or lateral recumbent position, after the first delay time has elapsed.

21 . The method of claim 20 , further comprising: gradually increasing a pulse amplitude of the delivered stimulation, upon activation.

22 . The method of claim 20 , further comprising: determining the position of the human subject periodically while in the first mode of operation and to enter a second mode of operation when the human subject is determined to have switched to a upright, standing, or sitting position; and

the second mode of operation comprises a state to pause the delivery of stimulation, and to resume the delivery of stimulation after the human subject is determined to have returned to a supine, prone or lateral recumbent position.

23 . The method of claim 22 , further comprising: resuming the delivery of stimulation in the second mode of operation after a preset second delay timer.

24 . The method of claim 16 , further comprising: causing the stimulation system to deliver stimulation to the nerve which innervates an upper airway muscle of the human subject only after determining that the human subject is asleep and has transitioned to a supine position from a prone or lateral position.

25 . The method of claim 24 , further comprising: determining that the subject has rolled on their back based on the collected sensor data.

26 . The method of claim 24 , further comprising: delivering stimulation to the nerve which innervates an upper airway muscle of the human subject only while the human subject is in a supine position.

27 . The method of claim 16 , further comprising: obtaining, from a clinician or the human subject, a selection of one or more settings for the delivery of stimulation, wherein the one or more settings comprise a setting allowing or prohibiting the delivery of the stimulation based on a position of the human subject.

28 . The method of claim 27 , wherein the one or more settings comprise a setting allowing or prohibiting the delivery of the stimulation when the human subject is determined to be in a supine, prone, or lateral position.

29 . A implantable system for treating obstructive sleep apnea (OSA) in a human subject, comprising:

one or more sensors, wherein each sensor is configured to collect sensor data indicative of respiratory activity or a physical state of the human subject when placed on, in proximity to, or implanted in, the human subject; and

a controller communicatively linked to the one or more sensors and configured to;

receive the sensor data from the one or more sensors,

determine one or more respiratory parameters for the human subject, using the sensor data,

calculate a standard deviation or a variance of the one or more respiratory parameters over a trailing window comprising 75-120 time points or a time range of 5-8 minutes, and

classify the human subject as being awake or asleep by comparing the calculated standard deviation or a variance against a predetermined threshold; and

a stimulation system, communicatively linked to the controller and configured to deliver stimulation to a nerve which innervates an upper airway muscle of the human subject based on the classification by the controller, wherein the controller is configured to cause the stimulation system to activate the delivery of stimulation to the nerve when the controller detects a transition in the position of the human subject.